Schedule 13G ownership disclosure

Ultragenyx Pharmaceutical Inc

Security class unavailable · CUSIP: 90400D108

Event date: 2019-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,259,962
Percent of class
5.6500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000457
Form type
SC 13G/A
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Oct 10, 2019
Reporting period
Sep 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub